|
|
 |
In tens, please (ten pound notes) para que serve o remdio naproxeno 550 mg The company, best-known for its HIV/AIDS treatments, has submitted a New Drug Application to the US Food and Drug Administration for idelalisib, a targeted, oral inhibitor of PI3K delta, for the treatment of indolent non-Hodgkin’s lymphoma (iNHL). Specifically, the company says the data submitted in the NDA support the use of idelalisib for patients with iNHL that do not respond to Roche and Biogen Idec’s blockbuster Rituxan (rituximab) and to alkylating-agent-containing chemotherapy.
2021-2-2 10:43:31 |
|
|
|
